Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
U.S. Army Medical Research & Development Command
investment firm
About
USAMRMC is conducts research to deliver the medical solutions to enhance, protect and treat the warfighter.
Highlights
Details
- Founded date
- Nov 3, 1994
- Operating Status
- Active
- Legal Name
- U.S. Army Medical Research & Development Command
Investments
Number of Investments
Number of Lead Investments
7
6
U.S. Army Medical Research & Development Command has made 7 investments. Their most recent investment was on
May 26, 2021, when Inhalon Biopharma raised $7M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 26, 2021
Inhalon Biopharma
|
Grant | $7M | Biopharma | Yes |
|
May 18, 2021
Oculogica
|
Grant | $2M | Health Care | Yes |
|
Sep 24, 2020
Lumen Bioscience
|
Grant | $4M | Biopharma | Yes |
|
Feb 19, 2018
Medcura
|
Grant | $1.40M | Health Care | Yes |
|
Aug 14, 2017
Cytosorbents
|
Grant | $719K | Biotechnology | Yes |
Exits
U.S. Army Medical Research & Development Command has had 3 exits. U.S. Army Medical Research & Development Command most notable exits include SmartCells , Cytosorbents
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 2, 2010 | SmartCells | M&A | Biotechnology | Detail |
| Aug 18, 2006 | Cytosorbents | IPO | Biotechnology | Detail |
| Feb 20, 1998 | Lexicon Pharmaceuticals | IPO | Bioinformatics | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
